Safety Concerns with Nusinersen, Risdiplam, and Onasemnogene Abeparvovec in Spinal Muscular Atrophy: A Real-World Pharmacovigilance Study

Zhuang, W; Lu, M; Wu, Y; Chen, ZH; Wang, MY; Wang, XD; Guan, SX; Lin, WL

Lin, WL (通讯作者)，Xiamen Univ, Women & Childrens Hosp, Sch Med, Dept Pharm, 10 Zhenhai Rd, Xiamen, Peoples R China.

CLINICAL DRUG INVESTIGATION, 2023; ():

Abstract

Background and ObjectiveSpinal muscular atrophy (SMA) is a genetic disorder with limited treatment options. It is crucial to have a comprehensive unde......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索